Bridgeway Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,507
| Closed | -$657K | – | 1405 |
|
|
2022
Q1 | $657K | Sell |
20,507
-40,000
| -66% | -$1.28M | 0.01% | 875 |
|
|
2021
Q4 | $1.32M | Hold |
60,507
| – | – | 0.02% | 735 |
|
|
2021
Q3 | $1.33M | Hold |
60,507
| – | – | 0.03% | 747 |
|
|
2021
Q2 | $1.18M | Sell |
60,507
-7,500
| -11% | -$146K | 0.02% | 806 |
|
|
2021
Q1 | $1.17M | Buy |
68,007
+14,300
| +27% | +$246K | 0.02% | 801 |
|
|
2020
Q4 | $861K | Hold |
53,707
| – | – | 0.02% | 780 |
|
|
2020
Q3 | $573K | Buy |
53,707
+18,800
| +54% | +$201K | 0.01% | 839 |
|
|
2020
Q2 | $425K | Buy |
+34,907
| New | +$425K | 0.01% | 905 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1383 |
|
|
2019
Q4 | – | Sell |
-8,110
| Closed | -$127K | – | 1411 |
|
|
2019
Q3 | $127K | Sell |
8,110
-1,250
| -13% | -$19.6K | ﹤0.01% | 1229 |
|
|
2019
Q2 | $210K | Sell |
9,360
-3,843
| -29% | -$86.2K | ﹤0.01% | 1170 |
|
|
2019
Q1 | $903K | Buy |
13,203
+5,703
| +76% | +$390K | 0.01% | 796 |
|
|
2018
Q4 | $396K | Buy |
7,500
+1,875
| +33% | +$99K | 0.01% | 1070 |
|
|
2018
Q3 | $383K | Buy |
5,625
+1,517
| +37% | +$103K | ﹤0.01% | 1202 |
|
|
2018
Q2 | $486K | Sell |
4,108
-1,250
| -23% | -$148K | ﹤0.01% | 1144 |
|
|
2018
Q1 | $444K | Buy |
5,358
+1,250
| +30% | +$104K | ﹤0.01% | 1127 |
|
|
2017
Q4 | $613K | Hold |
4,108
| – | – | 0.01% | 1034 |
|
|
2017
Q3 | $255K | Buy |
4,108
+750
| +22% | +$46.6K | ﹤0.01% | 1237 |
|
|
2017
Q2 | $157K | Hold |
3,358
| – | – | ﹤0.01% | 1324 |
|
|
2017
Q1 | $205K | Sell |
3,358
-3,650
| -52% | -$223K | ﹤0.01% | 1276 |
|
|
2016
Q4 | $418K | Sell |
7,008
-1,375
| -16% | -$82K | 0.01% | 1142 |
|
|
2016
Q3 | $610K | Buy |
8,383
+7,008
| +510% | +$510K | 0.01% | 997 |
|
|
2016
Q2 | $109K | Buy |
+1,375
| New | +$109K | ﹤0.01% | 1378 |
|